O-GlcNAcase inhibitors reported in Tyk Medicines patent
O-GlcNAcase inhibitors reported in Tyk Medicines patent
O-GlcNAcase inhibitors reported in Tyk Medicines patent
A compact weekly email covering company moves, product signals, regulatory updates, and notable funding.